Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Pain, Postoperative 10Breast Neoplasms 5Pain 4Agnosia 3Rectal Neoplasms 2Lung Neoplasms 2Leiomyoma 2Colonic Neoplasms 2post laminectomy syndrome 1Uterine Cervical Dysplasia 1Upper Abdominal Cancer Surgery 1Prostatic Neoplasms 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Neuroma 1Neuralgia 1Neoplasms 1Myoma 1Lymphedema 1Kidney Neoplasms 1Intestinal Diseases 1Inflammatory Bowel Diseases 1Ileus 1Hot Flashes 1Hemorrhage 1Head and Neck Neoplasms 1Gynecologic Surgical Procedures 1Gastrointestinal Neoplasms 1Gastrointestinal Diseases 1Failed Back Surgery Syndrome 1Diverticulosis, Colonic 1

Interventions

Fentanyl 1Bupivacaine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 4 × Failed Back Surgery Syndrome × Bupivacaine × Clear all
NCT03523000 2023-01-12

Determining the Prognostic Value of Continuous Intrathecal Infusion

University Hospitals Cleveland Medical Center

Phase 4 Completed
36 enrolled 14 charts

post laminectomy syndrome, Failed Back Surgery Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡